At the news
? NEUTRALIMPACT 1/10 6-K filed Nov 2, 2026 at 10:23 ET
AstraZeneca filed a routine total voting rights notification under UK Disclosure and Transparency Rules, reporting 1,551,065,237 ordinary shares with voting rights as of 31 October 2026, with no shares held in treasury. This is a periodic administrative disclosure with no financial results or material corporate events.
- Issued share capital with voting rights: 1,551,065,237 ordinary shares of US$0.25 each as of 31 October 2026
- No shares held in treasury
- Total voting rights: 1,551,065,237
- Filing made under UK FCA Disclosure and Transparency Rule 5.6.1
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access